Clinical Trials Logo

Clinical Trial Summary

Chinese herbal tea bags can adjust physiological functions, help protect power, and give positive energy to the body. This prescription not only focuses on regulating the patient's physical function, but also helps to enhance physical strength.


Clinical Trial Description

In Taiwan ,acoording to the TCM theories and viewpoints, Chinese herbal medicine plays an important role in clinical drug application.TCM compound combinations for different diseases, emphasizing the complementarity and balance of ingredients, natural gentleness, uniqueness and efficacy are widely accepted by the public. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04702659
Study type Observational
Source Taipei Veterans General Hospital, Taiwan
Contact
Status Completed
Phase
Start date January 10, 2021
Completion date June 15, 2022

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05739071 - JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer N/A
Recruiting NCT05846451 - Evaluating a Potential Pharmacokinetic Kratom-oxycodone Interaction Concurrent With Clinical Endpoints Early Phase 1
Completed NCT04974073 - Development of PHY606 as Adjunct Therapy for Anemia Patients Phase 3
Enrolling by invitation NCT05504447 - To Evaluate the Efficacy and Safety of "Rongyang Zhengyifang" Tea Bag With COVID-19 Variant Virus N/A